Dr. Erik Doevendans
Doevendans has over 20 years’ industry experience in CMC and a
background in quality assurance, medicinal assessments, regulatory affairs and
manufacturing operations. He started his own consultancy in 2007 and joined CNS
Biodesk as a principal consultant in 2015. Notably Erik was previously a
pharmaceutical assessor at the Dutch Medicines Board and an expert to the
Erik obtained a MSc in Pharmacy at Utrecht University, where he is still involved in the department of Pharmaceutics, with special interest in biosimilars and the relevancy of animal models used in non-clinical development.